Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Tan Sheet

Executive Summary

Bladderwrack, epigallocatechin-3-gallate (green tea extract polyphenol), grape seed and pine bark extracts accepted for carcinogenicity testing by program's Interagency Committee for Chemical Evaluation & Coordination, July 25 Federal Register notice states. National Cancer Institute nominated three ingredients, noting they have "significant exposure" to public through use in dietary supplements. ICCEC represents National Toxicology Program's first level of review; at May 25 meeting, program's Board of Scientific Counselors endorsed testing for SAM-e, black cohosh, blue-green algae, bilberry fruit extract, senna, yohimbe bark extract and hydergine (1"The Tan Sheet" June 4, p. 6)

You may also be interested in...

Supplement Composite Samples Best For NTP Study

The National Toxicology Program should use com-posite samples of products from multiple manufac-turers in its studies of dietary supplement ingredients, Clay Frederick, PhD, Rohm & Haas, suggested at the NTP Board of Scientific Counselors meeting in Research Triangle Park, N.C. May 25.

People In Brief

Perrigo promotes in pricing, planning

In Brief

Combe sells most of its OTC brands





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts